<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">

Living Tumor Bank and Patient-Derived Xenograft Models: A Powerful Translational Engine for Novel Oncology Therapeutics

Patient-derived xenograft (PDX) models have been established from the world’s largest living tumor bank at Molecular Response and used to mimic clinical trial settings with patients from diverse populations and heterogeneous disease; these models are being used to test novel compounds in a more predictive preclinical setting.